OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 12/29/2023
Week ended 12/29/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 12/29/2023
- The Only M&A Deal of the Week:
- On December 28, 2023, 22nd Century Group Inc. (XXII: Nasdaq), an agricultural biotech company focused on tobacco harm reduction and reduced nicotine tobacco, completed the sale of its hemp/cannabis operations to Specialty Acquisition Corporation, a Nevada-based investment company.
- The total consideration of $2.25M was composed of $1.00M in cash and $1.25M in Seller Notes.
- XXII will reduce both debt and operating costs through the transaction.
Week ended 12/29/2023
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.